Colgate-Palmolive Company $CL Position Raised by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 6.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 27,128 shares of the company’s stock after purchasing an additional 1,726 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Colgate-Palmolive were worth $2,466,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of CL. Grimes & Company Inc. grew its holdings in Colgate-Palmolive by 1.0% during the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after acquiring an additional 118 shares during the period. RFG Advisory LLC lifted its holdings in Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after acquiring an additional 123 shares during the last quarter. Tiemann Investment Advisors LLC boosted its position in shares of Colgate-Palmolive by 2.1% during the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares in the last quarter. Redhawk Wealth Advisors Inc. grew its stake in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after purchasing an additional 129 shares during the last quarter. Finally, Westside Investment Management Inc. raised its holdings in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $80.14 on Friday. The company has a market capitalization of $64.59 billion, a price-to-earnings ratio of 22.51, a P/E/G ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock’s fifty day simple moving average is $78.57 and its 200-day simple moving average is $84.54.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same period last year, the company posted $0.91 EPS. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 17th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. Colgate-Palmolive’s payout ratio is presently 58.26%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. UBS Group decreased their price target on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a report on Monday, November 3rd. Piper Sandler initiated coverage on Colgate-Palmolive in a research report on Friday, October 3rd. They set a “neutral” rating and a $84.00 target price on the stock. Morgan Stanley decreased their price target on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Finally, Evercore ISI dropped their price target on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research note on Monday, November 3rd. Nine research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $89.87.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.